ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation.
Konduri KS, Pattisapu R, Pattisapu J, Konduri GG, Zwetchkenbaum J, Roy B, Barman M, Frazier A, Hurst BL, Düzgüneş N.
Konduri KS, et al. Among authors: duzgunes n.
Arch Pharmacol Ther. 2021;3(2):52-65. doi: 10.33696/pharmacol.3.028.
Arch Pharmacol Ther. 2021.
PMID: 34766166
Free PMC article.